Who are Betamethasone and local anesthetic's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/betamethasone-and-local-anesthetic.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Betamethasone and local anesthetic — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Betamethasone and local anesthetic (Betamethasone and local anesthetic) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid with local anesthetic. Area: Dermatology, Rheumatology, Pain Management.

marketed Corticosteroid with local anesthetic Glucocorticoid receptor (betamethasone); voltage-gated sodium channels (local anesthetic component) Dermatology, Rheumatology, Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Betamethasone and local anesthetic (Betamethasone and local anesthetic) — Jakob Møller Hansen, MD.. Betamethasone reduces inflammation and immune response while the local anesthetic component provides pain relief at the site of administration.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Betamethasone and local anesthetic TARGET	Betamethasone and local anesthetic	Jakob Møller Hansen, MD.	marketed	Corticosteroid with local anesthetic	Glucocorticoid receptor (betamethasone); voltage-gated sodium channels (local anesthetic component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid with local anesthetic class)

Jakob Møller Hansen, MD. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Betamethasone and local anesthetic — Competitive Intelligence Brief. https://druglandscape.com/ci/betamethasone-and-local-anesthetic. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab